What development phase is Cliradon in?

Cliradon is FDA-approved (marketed).

What is the generic name of Cliradon?

KETOBEMIDONE is the generic (nonproprietary) name of Cliradon.

Last reviewed 2026-04-20 · How we verify

Cliradon (KETOBEMIDONE)

FDA-approved active Small molecule Quality 15/100

At a glance

Generic name	KETOBEMIDONE
Drug class	ketobemidone
Target	Delta-type opioid receptor, Glutamate receptor ionotropic, NMDA 3A, Kappa-type opioid receptor
Modality	Small molecule
Therapeutic area	Pain
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Cliradon CI brief — competitive landscape report
Cliradon updates RSS · CI watch RSS